Print ISSN: 2393-9079
Online ISSN: 2393-9087
CODEN : IJPPTK
Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...Review Article
Author Details :
Volume : 3, Issue : 4, Year : 2016
Article Page : 152-154
Abstract
According to a world health organization survey, about 75-80% of the world’s population relies on non-conventional medicine, mainly of herbal source, in their primary health care. In the past few decades, a massive amount of scientific information published for various medicinal plants. Cissampelospareira is a plant whose various parts are commonly used in various aliments. There is vast anecdotal information about the biological activity C.pareira which includes anti-cancerous, anti-fertility, anti-asthmatic, anti-diabetic, analgesic, hepatoprotective and anti- inflammatory type of activities. The leaf of C. pareira contains various phytoconstituents including alkaloids, terpenoids and flavonoids. The present review comprises the phytochemical, ethnopharmacological and pharmacological reports of C.pareira.
Keywords: Cissampelospareira, Hepatoprotective, Anti-fertility, Anti-asthmatic analgesic and anti- inflammatory activities
How to cite : Wimpy K, Yadav Sk, Kumkum M, Manoj G, Phytochemical and pharmacological review on Cissampelospareira. Indian J Pharm Pharmacol 2016;3(4):152-154
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.